$36.14

-0.84 (-2.27%)

Weekly Expected Move ±3.0%

$34 $36 $37 $38 $39

NYSE · Real Estate · REIT - Healthcare Facilities · Tech Score Neutral · Power 49 · $8.5B mcap · 234M float · 1.06% daily turnover · Short 48% of daily vol

Credit Risk of going bust: not rated, financial company (lending is its business) Bonds: $44.7M held by 60 funds, 106 bp over Treasuries → details ▾

Not rated: lending and leverage are a financial company's business, which the model misreads.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$477M +108.8% ▲

5Y CAGR: +22.1%

Gross Profit

$282M +31.2% ▲

5Y CAGR: +10.5%

Operating Income

$320M +158.1% ▲

5Y CAGR: +25.7%

Net Income

$321M +156.3% ▲

5Y CAGR: +31.7%

EPS (Diluted)

$1.57 +96.2% ▲

5Y CAGR: +21.2%

EBITDA

$462M +118.4% ▲

5Y CAGR: +24.0%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$190M	$188M	$199M	$228M	$477M
YoY Growth	+8.3%	-1.4%	+5.9%	+14.9%	+108.8%
Cost of Revenue	$4M	$9M	$10M	$14M	$195M
Gross Profit	$187M	$178M	$189M	$215M	$282M
Gross Margin	98.1%	95.0%	95.2%	94.1%	59.1%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$27M	$19M	$21M	$28M	$138K
Operating Expenses	$82M	$74M	$73M	$91M	-$38M
Operating Income	$104M	$104M	$116M	$124M	$320M
Operating Margin	54.9%	55.4%	58.4%	54.3%	67.2%
Interest Expense	$24M	$30M	$41M	$30M	$44M
Income Before Tax	$72M	-$8M	$54M	$124M	$325M
Tax Expense	$0	$0	$0	$0	$5M
Net Income	$72M	-$8M	$54M	$125M	$321M
Net Margin	37.8%	-4.0%	27.1%	54.8%	67.3%
EPS (Diluted)	$0.50	$0.44	$0.50	$0.80	$1.57
EBITDA	$151M	$73M	$146M	$212M	$462M
Shares Outstanding	96M	97M	106M	155M	204M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$57M	$62M	$72M	$86M	$104M	$135M	$143M	$161M
Cost of Revenue	$6M	$3M	$2M	$3M	$3M	$55M	$62M	$11M
Gross Profit	$52M	$59M	$69M	$83M	$102M	$80M	$81M	$151M
Gross Margin	90.2%	94.7%	97.0%	96.4%	97.5%	58.9%	56.9%	93.5%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$6M	$9M	$9M	$12M	$15M	-$36M	$0	$16M
Operating Expenses	$21M	$30M	$27M	$34M	$42M	-$7M	-$12M	$46M
Operating Income	$31M	$29M	$43M	$49M	$60M	$87M	$93M	$104M
Operating Margin	54.0%	47.0%	59.5%	57.2%	57.1%	64.1%	65.1%	64.6%
Interest Expense	$8M	$5M	$7M	$13M	$13M	$11M	$11M	$15M
Income Before Tax	$33M	$52M	$65M	$69M	$77M	$114M	$82M	$91M
Tax Expense	$0	$0	$0	$1M	$2M	$2M	$2M	$3M
Net Income	$33M	$52M	$66M	$69M	$75M	$111M	$80M	$89M
Net Margin	58.5%	83.8%	91.8%	79.7%	71.8%	82.4%	56.2%	55.2%
EPS (Diluted)	$0.21	$0.29	$0.35	$0.35	$0.35	$0.52	$0.36	$0.38
EBITDA	$56M	$73M	$90M	$103M	$116M	$153M	$122M	$137M
Shares Outstanding	160M	182M	187M	193M	212M	204M	224M	234M

CTRE NYSE